How does apolipoprotein E genotype influence the relationship between physical activity and Alzheimer's disease risk? A novel integrative model
- PMID: 36707869
- PMCID: PMC9881295
- DOI: 10.1186/s13195-023-01170-4
How does apolipoprotein E genotype influence the relationship between physical activity and Alzheimer's disease risk? A novel integrative model
Abstract
Background: Wide evidence suggests that physical activity (PA) confers protection against Alzheimer's disease (AD). On the other hand, the apolipoprotein E gene (APOE) ε4 allele represents the greatest genetic risk factor for developing AD. Extensive research has been conducted to determine whether frequent PA can mitigate the increased AD risk associated with APOE ε4. However, thus far, these attempts have produced inconclusive results. In this context, one possible explanation could be that the influence of the combined effect of PA and APOE ε4 carriage might be dependent on the specific outcome measure utilised.
Main body: In order to bridge these discrepancies, the aim of this theoretical article is to propose a novel model on the interactive effects of PA and APOE ε4 carriage on well-established mechanisms underlying AD. Available literature was searched to investigate how PA and APOE ε4 carriage, independently and in combination, may alter several molecular pathways involved in AD pathogenesis. The reviewed mechanisms include amyloid beta (Aβ) and tau deposition and clearance, neuronal resilience and neurogenesis, lipid function and cerebrovascular alterations, brain immune response and glucose metabolism. Finally, combining all this information, we have built an integrative model, which includes evidence-based and theoretical synergistic interactions across mechanisms. Moreover, we have identified key knowledge gaps in the literature, providing a list of testable hypotheses that future studies need to address.
Conclusions: We conclude that PA influences a wide array of molecular targets involved in AD neuropathology. A deeper understanding of where, when and, most importantly, how PA decreases AD risk even in the presence of the APOE ε4 allele will enable the creation of new protocols using exercise along pharmaceuticals in combined therapeutic approaches.
Keywords: APOE ε4; Alzheimer’s disease; Amyloid pathology; Cerebrovascular health; Glucose metabolism; Mitochondrial dysfunction; Neuroinflammation; Neurotrophic factors; Physical activity; Tau pathology.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




Similar articles
-
Unraveling APOE4's Role in Alzheimer's Disease: Pathologies and Therapeutic Strategies.Curr Protein Pept Sci. 2025;26(4):259-281. doi: 10.2174/0113892037326839241014054430. Curr Protein Pept Sci. 2025. PMID: 39722484 Review.
-
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060. JAMA Psychiatry. 2014. PMID: 25162367
-
Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.Am J Pathol. 1996 Jun;148(6):2083-95. Am J Pathol. 1996. PMID: 8669492 Free PMC article.
-
Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.Mol Neurobiol. 2016 Sep;53(7):4539-47. doi: 10.1007/s12035-015-9388-7. Epub 2015 Aug 23. Mol Neurobiol. 2016. PMID: 26298664
-
Roles of ApoE4 on the Pathogenesis in Alzheimer's Disease and the Potential Therapeutic Approaches.Cell Mol Neurobiol. 2023 Oct;43(7):3115-3136. doi: 10.1007/s10571-023-01365-1. Epub 2023 May 25. Cell Mol Neurobiol. 2023. PMID: 37227619 Free PMC article. Review.
Cited by
-
Physical activity and APOE neuropathology score modify the association of age and [11C]-PiB-PET amyloid burden in a cohort enriched with risk for Alzheimer's disease.medRxiv [Preprint]. 2025 Mar 5:2025.03.01.25323157. doi: 10.1101/2025.03.01.25323157. medRxiv. 2025. PMID: 40093261 Free PMC article. Preprint.
-
Physical activity and blood-based biomarkers of neurodegeneration in community dwelling Australians from ISLAND (Island Study Linking Ageing and Neurodegenerative Disease).Alzheimers Dement (Amst). 2025 Aug 17;17(3):e70166. doi: 10.1002/dad2.70166. eCollection 2025 Jul-Sep. Alzheimers Dement (Amst). 2025. PMID: 40827139 Free PMC article.
-
Low to moderate ethanol exposure reduces astrocyte-induced neuroinflammatory signaling and cognitive decline in presymptomatic APP/PS1 mice.Sci Rep. 2024 Oct 14;14(1):23989. doi: 10.1038/s41598-024-75202-w. Sci Rep. 2024. PMID: 39402264 Free PMC article.
-
Targeting necroptosis in Alzheimer's disease: can exercise modulate neuronal death?Front Aging Neurosci. 2025 Mar 14;17:1499871. doi: 10.3389/fnagi.2025.1499871. eCollection 2025. Front Aging Neurosci. 2025. PMID: 40161268 Free PMC article. Review.
-
Association between Mineral Intake and Cognition Evaluated by Montreal Cognitive Assessment (MoCA): A Cross-Sectional Study.Nutrients. 2023 Oct 24;15(21):4505. doi: 10.3390/nu15214505. Nutrients. 2023. PMID: 37960158 Free PMC article.
References
-
- American College of Sports Medicine . ACSM’s guidelines for exercise testing and prescription. 10. Indianapolis: Wolters Kluwer; 2017. - PubMed
-
- Brown BM, Rainey-Smith SR, Dore V, Pfeiffer JJ, Burnham SC, Laws SM, et al. Self-reported physical activity is associated with tau burden measured by positron emission tomography. J Alzheimers Dis. 2018;63(4):1299–1305. - PubMed
-
- Lindsay J, Laurin D, Verreault R, Hébert R, Helliwell B, Hill GB, et al. Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol. 2002;156(5):445–453. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous